Updated:
Shenzhen Baiyeyuan Investment
Shenzhen Baiyeyuan Investment is a Shenzhen-based investment company. It manages approximately $6.3 billion in assets across two funds, primarily focusing on...
Shenzhen Baiyeyuan Investment
Shenzhen Baiyeyuan Investment is a Shenzhen-based investment company. It manages approximately $6.3 billion in assets across two funds, primarily focusing on Asia.
General information
Firm type
Generalist
Year founded
2004
Location
Region
Asia
Country
China
City
Shenzhen
Corporate office
Shenzhen, China
Principals
Zhu Baoguo
Founder
Liu Guangxia
Vice Chairman, Joincare
Sector focus
Frequently asked questions
Who runs investment decisions at Shenzhen Baiyeyuan Investment?
Founder Zhu Baoguo is the de facto controller with a 90% ownership stake, making him the central decision-maker on all capital allocations. His spouse, Liu Guangxia, holds the remaining 10% but there is no public evidence of a formal investment committee or external advisors shaping the portfolio. The governance structure is personal and concentrated, typical of Chinese industrialist family investment vehicles.
What is Shenzhen Baiyeyuan Investment's relationship to Joincare Pharmaceutical?
The firm's capital originates from Joincare Pharmaceutical Group, where Zhu Baoguo is chairman and his spouse is vice-chairman. Shenzhen Baiyeyuan directly holds the Joincare Pharmaceutical Group Building in Shenzhen as a commercial property asset, and the investment company functions as a separate entity for managing wealth accumulated from the pharmaceutical business.
What is the WeBank investment, and why is it significant?
WeBank is China's first digital-only bank, launched in 2014 with Tencent as the lead shareholder at 30%. Shenzhen Baiyeyuan Investment holds a 20% equity stake, equal to co-investor Shenzhen Liye Group, making it the second-largest shareholder. The position ties Baiyeyuan directly to Tencent's fintech strategy and represents a large, concentrated bet on China's digital banking sector.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: